首页> 中国专利> 改善亚健康口服剂和认识宇宙生命的方程模型理论

改善亚健康口服剂和认识宇宙生命的方程模型理论

页面导航

著录项
法律信息
相似文献

摘要

著录项

公开/公告号CN102342521A

专利类型发明专利
公开/公告日2012-02-08

原文格式PDF
申请/专利权人李文金;
展开▼

申请/专利号CN201110223242.3
发明设计人李文金;
展开▼

申请日2009-06-12
分类号A23L1/302;A23L1/304;
代理机构
代理人
地址 430012 湖北省武汉市江岸区建设新村300号武汉机电工程学校李艳飞转李文金
入库时间 2023-12-18 04:34:25

法律信息

法律状态公告日

法律状态信息

法律状态
2013-08-28

发明专利申请公布后的驳回 IPC(主分类):A23L1/302 申请公布日:20120208 申请日:20090612

发明专利申请公布后的驳回
2012-04-04

实质审查的生效 IPC(主分类):A23L1/302 申请日:20090612

实质审查的生效
2012-02-08

公开

公开

相似文献

专利
中文文献
外文文献

1. 改善亚健康口服剂和认识宇宙生命的方程模型理论 [P] . 中国专利： CN102342521A . 2012-02-08
2. 改善成年人亚健康症状的口服剂 [P] . 中国专利： CN101700119A . 2010-05-05
3. POLYMIXIN DERIVATIVE OF THE GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; METHOD FOR THE TREATMENT, RELIEF OR IMPROVEMENT OF AN INFECTION, IN A PATIENT, CAUSED BY A GRAM-NEGATIVE BACTERIA; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA TO AN ANTIBACTERIAL AGENT; METHOD FOR THE DEVELOPMENT OF UNPUBLISHED ANTIBIOTICS; METHODS FOR REDUCING THE TOXICITY OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING THE APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD TO IMPROVE PHARMACOKINETIC PROPERTIES, OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR THE AWARENESS OF CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA TO A DEFENSE MECHANISM COMPLEMENT IN THE SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A POLYMIXIN DERIVATIVE OF FORMULA (I) [P] . NO341982B1 . 2018-03-05

机译：一般配方的多聚新霉素衍生物（I）;组合产品;药物成分;革兰氏阴性菌引起的患者感染的治疗，缓解或改善的方法;将革兰氏阴性细菌敏化为抗菌剂的方法;开发未发表的抗生素的方法;在个体感染治疗中降低多粘菌素，天然八肽及其衍生物毒性的方法;改善多聚体，天然螯合剂及其衍生物的药动学性质的方法;认识临床上重要的革兰氏阴性细菌对血清中防御机制的补充;使用衍生词;的多聚新霉素衍生物的制备和方法（I）
4. POLYMIXIN DERIVATIVE OF THE GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; METHOD FOR THE TREATMENT, RELIEF OR IMPROVEMENT OF AN INFECTION, IN A PATIENT, CAUSED BY A GRAM-NEGATIVE BACTERIA; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA TO AN ANTIBACTERIAL AGENT; METHOD FOR THE DEVELOPMENT OF UNPUBLISHED ANTIBIOTICS; METHODS FOR REDUCING THE TOXICITY OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING THE APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD TO IMPROVE PHARMACOKINETIC PROPERTIES, OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR THE AWARENESS OF CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA TO A DEFENSE MECHANISM COMPLEMENT IN THE SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A POLYMIXIN DERIVATIVE OF FORMULA (I) [P] . BRPI0715095A2 . 2013-10-15

机译：一般配方的多聚新霉素衍生物（I）;组合产品;药物成分;革兰氏阴性菌引起的患者感染的治疗，缓解或改善的方法;将革兰氏阴性细菌敏化为抗菌剂的方法;开发未发表的抗生素的方法;在个体感染治疗中降低多粘菌素，天然八肽及其衍生物毒性的方法;改善多聚体，天然螯合剂及其衍生物的药动学性质的方法;认识临床上重要的革兰氏阴性细菌对血清中防御机制的补充;使用衍生词;的多聚新霉素衍生物的制备和方法（I）
5. POLYMIXIN DERIVATIVE OF THE GENERAL FORMULA (I); COMBINATION PRODUCT; PHARMACEUTICAL COMPOSITION; METHOD FOR THE TREATMENT, RELIEF OR IMPROVEMENT OF AN INFECTION, IN A PATIENT, CAUSED BY A GRAM-NEGATIVE BACTERIA; METHOD FOR SENSITIZING GRAM-NEGATIVE BACTERIA TO AN ANTIBACTERIAL AGENT; METHOD FOR THE DEVELOPMENT OF UNPUBLISHED ANTIBIOTICS; METHODS FOR REDUCING THE TOXICITY OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES DURING THE APPLICATION OF THE SAME IN THE TREATMENT OF INFECTIONS IN AN INDIVIDUAL; METHOD TO IMPROVE PHARMACOKINETIC PROPERTIES, OF POLYMIXINS, NATURAL OCTAPEPTINS AND THEIR DERIVATIVES; METHOD FOR THE AWARENESS OF CLINICALLY IMPORTANT GRAM-NEGATIVE BACTERIA TO A DEFENSE MECHANISM COMPLEMENT IN THE SERUM; USE OF A DERIVATIVE; AND PROCESS FOR THE PREPARATION OF A POLYMIXIN DERIVATIVE OF FORMULA (I) [P] . NO20090674L . 2009-05-08

机译：一般配方的多聚新霉素衍生物（I）;组合产品;药物成分;革兰氏阴性菌引起的患者感染的治疗，缓解或改善的方法;将革兰氏阴性细菌敏化为抗菌剂的方法;开发未发表的抗生素的方法;在个体感染治疗中降低多粘菌素，天然八肽及其衍生物毒性的方法;改善多聚体，天然螯合剂及其衍生物的药动学性质的方法;认识临床重要的革兰氏阴性细菌对血清中防御机制的补充;使用衍生词;的多聚新霉素衍生物的制备和方法（I）